Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up

The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group·2016·Diabetes Care
DOI 10.2337/dc15-1990

Cited by (712)

Items 701–712 of 712

  1. Early and sustained diabetes technology exposure is associated with cognitive outcomes in youth with type 1 diabetes
    Marta Bassi, Pasquale Capuozzo, Marta Scalas, Noemi Zampatti, Andreina Conte, Giordano Spacco, Andrea Pintabona, Alice Carla Luisa Parodi, Maria Grazia Calevo, Benedetta Salvadori et al. · 2026 · Diabetes Research and Clinical Practice
  2. Shifting competing underlying causes of death among U.S. decedents with diabetes recorded as a non-underlying cause, 1999–2024
    Yanhua Xiao, Qian Zhou, Xi Yan, 甘礼惠, Tong Chen, Kaiyi Zhang, Renqing Zeng, Dibin Guo, Xuezhi Hong · 2026 · Frontiers in Endocrinology
  3. Hand and shoulder diagnoses are associated with substantial bodily pain compared to vascular complications and long-term glycaemic control in people with long-term type 1 diabetes.
    Anne Karin Molvær, Marjolein M. Iversen, Jannicke Igland, Mark F. Peyrot, Grethe Seppola Tell, Tore Julsrud Berg · 2026 · Journal of Patient-Reported Outcomes
  4. Metabolic memory in diabetic complications: evidence for persistent cellular states and limits of therapeutic reversal
    Yulan Cai, Shuangyu He, Feng Zeng, Chuyu Liu · 2026 · Frontiers in Endocrinology
  5. Glycemic Status Modifies Retinal Structure–Function Coupling in Type 2 Diabetes Without Clinically Detectable Diabetic Retinopathy
    I‐Mo Fang, Fu‐Gong Lin, Kuo‐Meng Liao, Chu-Yu Yen · 2026 · Research Square
  6. Lactobacillus gasseri suppresses methionine-driven epigenetic programming of trained immunity-like priming to attenuate metabolic dysfunction
    Zheyu Fan, Yahan Yu, Chaorun Dong, Wenjie Bu, Yi Yu, Sisi Li, Zhiguo Wang, Yunlong Bai · 2026 · International Immunopharmacology
  7. Epigenetic Memory in Human Diseases: Acquired Chromatin States as Targetable Drivers of Disease Evolution
    Shahper N. Khan, Danishuddin, Salamatu Tijjani Isah, Mohammed Haris Siddiqui, Aamir Ahmad, Jong-Joo Kim · 2026 · Biomolecules
  8. Association Between the GMI / HbA1c Ratio and Microvascular Complications in Type 1 Diabetes: A Multicenter Cross‐Sectional Study
    Sandra Herranz-Antolín, Maria Asunción Martínez‐Brocca, Gloria Cánovas‐Molina, Aurora Aragón‐Alonso, Miguel Ángel Brito-Sanfiel, José Ignacio Martínez‐Montoro, Virginia Bellido, Sharona Azriel, María Carmen López-García, Cristina Tejera Pérez et al. · 2026 · Diabetes Obesity and Metabolism
  9. Decoding inflammation to target hybrid diabetes phenotypes
    Giada Rossi, Annalisa Terranegra, Maria Elena Lunati, Ida Pastore, LORENZO POZZI CANOVA, Loredana G Bucciarelli, Vincenzo Cimino, Cristian Loretelli, Moufida Ben Nasr, Paolo Fiorina et al. · 2026 · Frontiers in Endocrinology
  10. Maladie cardiovasculaire et diabète de type 1 : données épidémiologiques et physiopathologiques
    Bruno Vergès · 2026 · Médecine des Maladies Métaboliques
  11. Paradoxes in Modern Diabetes Care: Time, Context, Complexity, and the Limits of Biomarker-Based Reasoning
    Ferenc Sztanek · 2026 · Diabetology
  12. Diurnal variation of islet autoantibody titers in established type 1 diabetes suggests restricted-time sampling improves aab measurement and detection
    Craig A. Beam, Linda A. DiMeglio, C. Speake, K. Boest-Bjerg, O. Pearce, B. Almutairi, C. Evans-Molina, F. Wong, Anna E. Long, K. Gillespie et al. · 2026 · Scientific Reports